The Risk of Dementia with the Use of 5 Alpha Reductase Inhibitors

    Blayne Welk, Eric McArthur, Michael Ordon, Sarah A. Morrow, Jade Hayward, Stephanie N. Dixon
    Studysummary In this study, the use of 5 alpha reductase inhibitors was associated with an increased risk of dementia during the first two years of treatment, but the risk was not significant with longer exposure.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results